3.4 Signs and Symptoms of Breast Disease

3.4 Signs and Symptoms of Breast Disease

Patient Care on the mammography exam includes signs and symptoms of breast disease because the mammographer is often the first person who hears a new complaint at check-in. The clinical decision that follows is binary and high-yield: stay on screening or convert to diagnostic. Screening mammography is built for asymptomatic patients. Diagnostic mammography is problem-solving for a clinical finding or a screen-detected abnormality. Putting a palpable mass into a four-view screening slot delays extra views and ultrasound and can produce the wrong MQSA indication on the report.

You still do not diagnose. You ask, look, document, and route.

Pain

Breast pain (mastalgia) is one of the most common complaints and one of the weakest predictors of malignancy when it is diffuse, bilateral, and cyclic with the menstrual cycle. That pattern is often hormonal. It still belongs on the history because it explains why the patient is anxious and because your facility may have a local rule that any pain is scheduled diagnostic.

Focal, new, unilateral pain — especially pain the patient can point to with one finger — is treated more seriously. It may still be cyst, strain, or costochondritis, but it is the pain pattern that more often gets diagnostic mammography and targeted ultrasound so the radiologist can correlate. Do not tell the patient “pain means it isn’t cancer.” That sentence is both clinically false as an absolute and outside your role. Document location (clock face and distance from nipple), duration, and whether a mass is also felt.

Lump

A palpable lump is the classic reason to leave screening. Diagnostic mammography (often with a BB or other skin marker over the finding) plus targeted ultrasound is the usual next imaging step in women of typical screening age. In very young patients, ultrasound may lead; that order comes from the referring clinician or radiologist, not from a screening technologist deciding to skip mammography. Describe what the patient or clinician felt: size, clock position, depth, how long it has been present, whether it changes with the cycle, and whether there is associated skin change. If you feel a lump the patient did not mention, document it and notify the radiologist rather than ignoring it to “keep the schedule.”

A lump in a patient with implants, after lumpectomy, or along a reconstruction flap is still a lump. Postsurgical fat necrosis and scar can mimic mass; that is why comparison and diagnostic technique exist. It is not a reason to call the finding “just scar” at the gantry.

Nipple discharge

Discharge is sorted by laterality, spontaneity, and color/character.

Concerning pattern: unilateral, spontaneous (appears without squeezing), and bloody, serous, or clear/watery. That pattern raises concern for an intraductal lesion, including papilloma or, less often, ductal carcinoma. Those patients need diagnostic imaging — mammography and usually ultrasound — not a screening appointment. Some practices add ductography or MRI later; that is the radiologist’s algorithm.

Less concerning pattern: bilateral, only with compression, and green, yellow, or milky discharge. Bilateral milky discharge (galactorrhea) outside the peripartum period is often medication- or endocrine-related (prolactin). Imaging may still be ordered if there is a mass or if the clinician wants a baseline, but the discharge itself is not handled like a unilateral bloody spout. Teach the difference; do not dismiss unilateral spontaneous blood as “probably milk.”

Ask whether discharge is reproducible, which duct it comes from if known, and whether the patient is pregnant, lactating, or on antipsychotics or other prolactin-raising drugs. Wear gloves; treat discharge as a body-fluid exposure. Do not milk the breast repeatedly “to show the radiologist” if your protocol uses a single documented sample or a smear per department policy.

Skin changes — thickening, erythema, dimpling

Dimpling or retraction of skin can reflect Cooper’s ligament tethering by a mass. Focal skin thickening can be postsurgical, inflammatory, or malignant. Erythema (redness) and warmth overlap infection and inflammatory carcinoma. Photograph or diagram per protocol, mark the area if you will image it, and use clinical-history fields so the radiologist does not read “screening, asymptomatic” on a red, edematous breast.

New peau d’orange — skin that looks like orange peel because of dermal lymphatic edema — is an emergency-level clinical flag in breast imaging. It can be inflammatory carcinoma. It can also be severe mastitis or other obstruction of lymphatics. Either way, this is diagnostic, often same-day, with careful documentation of how much of the breast is involved.

Nipple and areolar changes

New nipple inversion or retraction, especially unilateral, is a symptom, not a cosmetic note. Long-standing bilateral inversion that the patient says is unchanged is less worrisome but still worth documenting. Scaling, crusting, ulceration, or persistent itching of the nipple–areola complex raises concern for Paget disease of the nipple, which is associated with underlying ductal carcinoma. Those patients need diagnostic imaging and clinical evaluation; a “skin cream and return next year for screening” plan is not your call and is the wrong slot.

Areolar distortion after surgery or piercing should be described so it is not mistaken for a new malignant retraction. Compare with the patient’s account of what is new.

Edema

Unilateral breast edema may be lymphatic obstruction from axillary disease, inflammatory carcinoma, radiation change, congestive heart failure (more often bilateral), or infection. Bilateral edema with a cardiac history is a different story than a single swollen red breast. Record laterality, speed of onset, fever if reported, lactation status, and recent radiation or axillary surgery. Edema changes technique: compression may be limited, skin may be fragile, and the radiologist may want additional views or ultrasound of the skin and axilla.

Which findings convert screening to diagnostic

Inflammatory carcinoma versus mastitis — overlap is the point

Mastitis and inflammatory breast carcinoma (IBC) can look alike: redness, warmth, swelling, pain, and peau d’orange. Mastitis is more common in lactating patients and more often comes with fever and a rapid response to antibiotics. IBC may have little or no fever, a breast that is swollen without a discrete mobile abscess, and failure to clear after a short antibiotic course. Peau d’orange is not pathognomonic of either one.

The mammographer’s job is identical in both stems: do not diagnose. Document lactation, fever, duration, laterality, and skin findings. Obtain the diagnostic images the protocol calls for (even when compression is limited). Alert the radiologist that this is an inflammatory-appearing breast. If the patient was sent as “screening,” stop and recode the indication. Telling a patient “it’s just a clogged duct” or “this is inflammatory cancer” are both errors — one delays a malignancy, the other inflicts a diagnosis you are not licensed to give.

After extra views, written MQSA results still apply. A diagnostic patient who hears a verbal impression in the department still needs the lay summary on the federal clock, including density language when a mammogram was performed. Symptoms change how you image and how urgently the clinician talks. They do not erase the results process in Section 3.1.